MCFAs show antibacterial properties, stimulate the peroxisome proliferator-activated receptor (PPAR), which results, among others, in a reduction of inflammation of the gut in patients with Crohn’s disease [79,80]. The gene discussed is PPARA; the disease is Crohn disease.